Pulmonary
  • Asthma
  • COPD
  • Pulmonary
amPulmonary Insights
amPulmonary Insights
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
Resources
  • Subscribe
  • About Us
  • Contact Us
  • Sign In
  • Sign In
  • Asthma
  • COPD
  • Pulmonary
  • Subscribe

Site Map

  1. 2023
  2. October
  3. 31
Research shows stigma hinders COPD treatment, leads to reduced funding
ReAlta Life Sciences receives FDA clearance for phase 2 trials of COPD treatment
The surprising impact of pulmonary ionocytes on CF
Inflammatory proteins could aid prognosis of PH patients
Welcome to your first issue of AM Pulmonary, your source of the latest information regarding pulmonary, asthma and COPD.
Page 1 of 1
Pulmonary
Newsletter for Professionals
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
  1. Privacy Policy
  2. About Us
  3. Terms & Conditions
  4. Contact Us
  5. Site Map
© 2025 Ascend Integrated Media. All rights reserved.